Insider filing · TARS
William J Phd Link
Director
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
William J Phd Link sold $1.8M of Tarsus Pharmaceuticals (TARS)
Executed Dec 15 2025, disclosed Dec 17 2025, 2 days later.
Value, as filed
$1.8M
21,798 sh across 4 lots
Executed
Dec 15 2025
the trade date, as filed
Disclosed
Dec 17 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WLWilliam J Phd Link (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $1.8M of TARS (21,798 sh across 4 lots, as filed), executed Dec 15 2025.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by William J Phd Link in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$915K11,675 sh × $78.33
Exec Sep 15
Filed Sep 17 · 4:22 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $776K
12,500 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $825K
12,007 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $1.5M
27,116 sh × $57.00
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET